N/A N=30 Other

The R4R Advance Care Planning Pilot Study

Advance Care Planning

Bottom Line

View on ClinicalTrials.gov: NCT06129149 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2025

Primary outcome: Primary: Advance Care Planning Values/Beliefs — 24.9; 26.3 Score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Trauma-Informed Care-adapted and Checklist-guided ACP intervention (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Vanderbilt University
Primary completion: Dec 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Advance Care Planning Values/Beliefs	24.9; 26.3	—
PRIMARY Advance Care Planning Processes	29.2; 43.8	—
PRIMARY Advance Care Planning Actions	8.6; 12.6	—
PRIMARY Implementation Acceptability	29	—
PRIMARY Implementation Appropriateness	24	—
PRIMARY Implementation Feasability	28	—

Summary

Affordable housing residents continue to experience multi-faceted insecurity and advance care planning (ACP) challenges even after obtaining secure housing, resulting in significant inequities in quality of care during times of cognitive incapacity. To promote proactive planning for affordable housing residents, this proposal is for a pilot study to test a novel trauma-informed care adapted advance care planning intervention with the following aims: to test initial efficacy of the intervention on ACP outcomes (Aim 1) and determine resident perceptions of intervention acceptability, appropriateness, and feasibility and perceived implementation barriers and facilitators (Aim 2). These data will support the development of a larger scale study of ACP interventions within a resiliency-based hub model to comprehensively support whole-person care and proactive planning for times of cognitive incapacity.

Eligibility Criteria

Inclusion Criteria

an adult (18+) residing in an affordable housing unit that does not have a completed advance directive

Exclusion Criteria

inability to provide informed consent or participate in the intervention due to cognitive, auditory, visual impairment or non-English language barrier

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06129149). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.